Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (121-130 of 309) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|November 7, 2015
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteersJosep Coll, José Moltó, Jaume Boix, et al.
The Journal of Infectious Diseases|December 7, 2019
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical ImpactHerbert A Mbunkah, Silvia Bertagnolio, Raph L Hamers, et al.
Journal of Virology|April 12, 2012
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressuresAthe M N Tsibris, Zixin Hu, Roger Paredes, et al.
AIDS Research and Human Retroviruses|June 9, 2016
A Summary of the First HIV Microbiome Workshop 2015Brett Williams, Paria Mirmonsef, Charles A B Boucher, et al.
Nature Communications|November 18, 2023
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis"Kristin Kostka, Elena Roel, Nhung T H Trinh, et al.
The Lancet. HIV|October 5, 2018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySeth C Inzaule, Raph L Hamers, Marc Noguera-Julian, et al.
The Journal of Infectious Diseases|September 27, 2003
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene StudyLidia Ruiz, Esteban Ribera, Anna Bonjoch, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2015
Determinants of virological failure and antiretroviral drug resistance in MozambiqueMaría Rupérez, Christian Pou, Sonia Maculuve, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAARTAnna Bonjoch, Roger Paredes, Juan Galvez, et al.
AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.
Pageof 31

Showing results (121-130 of 309) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|November 7, 2015
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteersJosep Coll, José Moltó, Jaume Boix, et al.
The Journal of Infectious Diseases|December 7, 2019
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical ImpactHerbert A Mbunkah, Silvia Bertagnolio, Raph L Hamers, et al.
Journal of Virology|April 12, 2012
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressuresAthe M N Tsibris, Zixin Hu, Roger Paredes, et al.
AIDS Research and Human Retroviruses|June 9, 2016
A Summary of the First HIV Microbiome Workshop 2015Brett Williams, Paria Mirmonsef, Charles A B Boucher, et al.
Nature Communications|November 18, 2023
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis"Kristin Kostka, Elena Roel, Nhung T H Trinh, et al.
The Lancet. HIV|October 5, 2018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySeth C Inzaule, Raph L Hamers, Marc Noguera-Julian, et al.
The Journal of Infectious Diseases|September 27, 2003
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene StudyLidia Ruiz, Esteban Ribera, Anna Bonjoch, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2015
Determinants of virological failure and antiretroviral drug resistance in MozambiqueMaría Rupérez, Christian Pou, Sonia Maculuve, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAARTAnna Bonjoch, Roger Paredes, Juan Galvez, et al.
AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.
Pageof 31